EPS Bio Technology Corp. Stock

Equities

4183

TW0004183009

Medical Equipment, Supplies & Distribution

End-of-day quote Taipei Exchange 06:00:00 2024-05-20 pm EDT 5-day change 1st Jan Change
22.45 TWD -0.66% Intraday chart for EPS Bio Technology Corp. +2.75% -15.12%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
Sales 2022 463M 14.36M Sales 2023 470M 14.56M Capitalization 630M 19.5M
Net income 2022 25M 774K Net income 2023 21M 651K EV / Sales 2022 0.83 x
Net cash position 2022 57.26M 1.77M Net cash position 2023 79.47M 2.46M EV / Sales 2023 1.17 x
P/E ratio 2022
17.5 x
P/E ratio 2023
30.1 x
Employees 116
Yield 2022
5.3%
Yield 2023
-
Free-Float 42.41%
More Fundamentals * Assessed data
Dynamic Chart
EPS Bio Technology Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
EPS Bio Technology Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
EPS Bio Technology Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
EPS Bio Technology Corp. Appoints Lin, Chih-Heng as Research and Development Officer CI
EPS Bio Technology Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
EPS Bio Technology Corp. Appoints Kuo,Po-Hsiung as Vice President and Financial Officer CI
EPS Bio Technology Corp. Announces Executive Changes CI
EPS Bio Technology Corp. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
EPS Bio Technology Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
EPS Bio Technology Corp. Announces Appointment of Members of Compensation Committee CI
EPS Bio Technology Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
EPS Bio Technology Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
EPS Bio Technology Corp. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
EPS Bio Technology Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Eps Bio Technology Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
More news
1 day-0.66%
1 week+2.75%
Current month+3.22%
1 month+6.40%
3 months+8.45%
6 months-19.82%
Current year-15.12%
More quotes
1 week
22.10
Extreme 22.1
22.80
1 month
21.15
Extreme 21.15
23.95
Current year
19.55
Extreme 19.55
26.95
1 year
19.55
Extreme 19.55
30.00
3 years
16.80
Extreme 16.8
30.00
5 years
13.95
Extreme 13.95
30.00
10 years
10.93
Extreme 10.93
51.57
More quotes
Managers TitleAgeSince
Chief Executive Officer - 11-03-23
Director/Board Member - 12-09-25
Investor Relations Contact - 06-07-14
Members of the board TitleAgeSince
Director/Board Member - 13-01-09
Chief Executive Officer - 11-03-23
Director/Board Member - 12-09-25
More insiders
Date Price Change Volume
24-05-20 22.45 -0.66% 19 000
24-05-20 22.6 +1.35% 41,228
24-05-17 22.3 +0.45% 14,000
24-05-16 22.2 0.00% 99,099
24-05-15 22.2 0.00% 118,121

End-of-day quote Taipei Exchange, May 20, 2024

More quotes
EPS Bio Technology Corp. is a Taiwan-based company principally engaged in the manufacture and sales of medical test strips and equipment. The Company's main products include blood glucose testers, blood glucose test strips and electric breast pumps. The Company distributes its products mainly to overseas markets, such as Europe, North America and the rest areas of Asia.
More about the company
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW